Heparin or heparan sulfate--what is the difference?

Pathophysiology of heparan sulphate: many diseases, few drugs.

Journal of internal medicine·2013

Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.

British journal of pharmacology·2010

Heparan sulphate requirement in platelet-derived growth factor B-mediated pericyte recruitment.

Biochemical Society transactions·2006

Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology.

Biochemical Society transactions·2003

Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.

Seminars in thrombosis and hemostasis·2001

Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis.

Biochimie·2001

Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.

Thrombosis and haemostasis·2026

Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma.

Thrombosis and haemostasis·2026

Elevated Factor VIIa-antithrombin Complexes Are Associated with Spontaneous Echo Contrast in Atrial Fibrillation: The Impact of Heart Failure.

Thrombosis and haemostasis·2026

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Thrombosis and haemostasis·2026

Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.

Thrombosis and haemostasis·2026

Room-Temperature Stability of Argatroban, Danaparoid, and Fondaparinux in Plasma: A Multicenter Study.

Thrombosis and haemostasis·2026

Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation.

Military medicine·2026

High prevalence of HTLV-1 among blood donors in southeastern Gabon (Central Africa): a major challenge for transfusion safety in a semi-rural area.

Microbiology spectrum·2026

Balancing Ischemia and Hemorrhage After Tenecteplase in Wake-Up Stroke.

JACC. Case reports·2026

Clot Composition Analysis in Peripheral Arterial Disease: A Systematic Review.

The International journal of angiology : official publication of the International College of Angiology, Inc·2026

Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis.

Therapeutic advances in neurological disorders·2026

Rationale and Methods of a Surveillance System for Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies: A Qualitative Participatory Action Research Approach in Middle-Income Countries-The Experience in Iran.

Health science reports·2026

Related Experiment Videos

Heparin or heparan sulfate--what is the difference?

Related Concept Videos

Pathophysiology of heparan sulphate: many diseases, few drugs.

Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.

Heparan sulphate requirement in platelet-derived growth factor B-mediated pericyte recruitment.

Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology.

Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.

Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis.

Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.

Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma.

Elevated Factor VIIa-antithrombin Complexes Are Associated with Spontaneous Echo Contrast in Atrial Fibrillation: The Impact of Heart Failure.

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.

Room-Temperature Stability of Argatroban, Danaparoid, and Fondaparinux in Plasma: A Multicenter Study.

Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation.

High prevalence of HTLV-1 among blood donors in southeastern Gabon (Central Africa): a major challenge for transfusion safety in a semi-rural area.

Balancing Ischemia and Hemorrhage After Tenecteplase in Wake-Up Stroke.

Clot Composition Analysis in Peripheral Arterial Disease: A Systematic Review.

Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis.

Rationale and Methods of a Surveillance System for Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies: A Qualitative Participatory Action Research Approach in Middle-Income Countries-The Experience in Iran.

Related Experiment Videos

Heparin or heparan sulfate--what is the difference?

Related Concept Videos

Related Articles